CARRIE CONLEY: Open Payments
NPI 1942500541 · FAIRBANKS, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $303 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $245 |
| AstraZeneca Pharmaceuticals LP | 10 | $219 |
| PFIZER INC. | 5 | $92 |
| Novo Nordisk Inc | 4 | $73 |
| Lilly USA, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| TMS NeuroHealth Centers Inc. | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, BREZTRI, QULIPTA, PAXLOVID, NURTEC ODT, Wegovy, Ozempic.
Industry payments across AK — which companies pay providers there.
